Neuroleptic malignant syndrome secondary to loxapine.
case_report · Level V
Where this comes from
- Record sourced from PubMed, PMID 1751872.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Loxapine was introduced to the British market two years ago although it has been used in North America for eight years. We report the first probable case of neuroleptic malignant syndrome (NMS) secondary to loxapine in Britain. Two previous cases have been reported in North America (manufacturer's data).
Medical subject headings
- Loxapine
- Neuroleptic Malignant Syndrome
- Schizophrenia
- Schizophrenic Psychology